ストックスクリーナーアプリを入手
2.06
17.05%
0.30
前日終値:
$1.76
開ける：
$1.78
24時間の取引高:
193.53K
Relative Volume:
1.24
時価総額：
$114.79M
収益：
-
当期純損益:
$-21.38M
株価収益率:
-5.2821
EPS:
-0.39
ネットキャッシュフロー:
$-25.19M
1週間 パフォーマンス:
+12.57%
1か月 パフォーマンス:
+17.71%
6か月 パフォーマンス:
+129.14%
1年 パフォーマンス:
+60.94%
1日の値動き範囲:
$1.78
$2.06
1週間の範囲:
$1.70
$2.06
52週間の値動き範囲:
$0.51
$2.86
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
名前
Connect Biopharma Holdings Ltd Adr
セクター
電話
858-727-1040
住所
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
CNTB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd Adr
|
2.06 | 98.07M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-13 | 開始されました | Jefferies | Buy |
| 2021-04-13 | 開始されました | Piper Sandler | Overweight |
| 2021-04-13 | 開始されました | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr (CNTB) 最新ニュース
Connect Biopharma (CNTB) Expected to Announce Quarterly Earnings on Friday - Defense World
Connect Biopharma Advances Clinical Trials and Nasdaq Listing - AInvest
Connect Biopharma Posts Q2 Revenue Drop - AOL.com
Q3 Earnings Estimate for CNTB Issued By Leerink Partnrs - Defense World
HC Wainwright Cuts Earnings Estimates for Connect Biopharma - Defense World
Connect Biopharma Reports Q2 Revenue Drop of 99.2% to $48,000, R&D Spending Increases 65.6% to $8.8mln - AInvest
Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView
Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Connect Biopharma Holdings Limited shares rise 5.63% after-hours following Jazz Pharmaceuticals' FDA approval of Modeyso. - AInvest
Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN
What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World
Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World
Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia
Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria
Connect Biopharma appoints Jim Schoeneck to board of directors - Investing.com Australia
Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria
Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks
Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com
Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com India
Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com
Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq
Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire
Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.
Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com India
Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa
Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com
Connect Biopharma Holdings shares rise 7.89% in after-hours after partner's new drug application for atopic dermatitis is accepted by NMPA. - AInvest
Connect Biopharma’s partner submits new drug application in China - Investing.com
Connect Biopharma’s partner submits new drug application in China By Investing.com - Investing.com South Africa
Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World
Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa
Connect Biopharma reports positive data for asthma treatment - Investing.com
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma Holdings Ltd Adr (CNTB) 財務データ
収益
当期純利益
現金流量
EPS
0.96%
1.09%
大文字化:
|
ボリューム (24 時間):